Terms: = Lung cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
35 results:
1. Missing prognostic value of soluble pd-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy - A CEPAC-TDM biomarker substudy.
Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
Tumour Biol; 2024; 46(s1):S355-S367. PubMed ID: 38277316
[TBL] [Abstract] [Full Text] [Related]
2. Spatial features of specific CD103
Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
J Transl Med; 2024 Jan; 22(1):27. PubMed ID: 38183111
[TBL] [Abstract] [Full Text] [Related]
3. Study on Targeted Drugs for Non-Small Cell NSCLC with pd-1PD-L1 Signaling Pathway.
Cao X
Stud Health Technol Inform; 2023 Nov; 308():562-567. PubMed ID: 38007784
[TBL] [Abstract] [Full Text] [Related]
4. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer.
Travelli C; Colombo G; Aliotta M; Fagiani F; Fava N; De Sanctis R; Grolla AA; Garcia JGN; Clemente N; Portararo P; Costanza M; Condorelli F; Colombo MP; Sangaletti S; Genazzani AA
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37880182
[TBL] [Abstract] [Full Text] [Related]
5. Mediastinal lymph node removal modulates natural killer cell exhaustion in patients with non-small cell lung cancer.
Cikman DI; Esen F; Engin A; Turna A; Agkoc M; Yilmaz A; Saglam OF; Deniz G; Aktas EC
Immunol Res; 2023 Dec; 71(6):959-971. PubMed ID: 37583002
[TBL] [Abstract] [Full Text] [Related]
6. Heterogeneous expression of predictive biomarkers PD-L1 and TIGIT in non-mucinous lung adenocarcinoma and corresponding lymph node metastasis: A challenge for clinical biomarker testing.
Kolb T; Benckendorff J; Möller P; Barth TFE; Marienfeld RB
Neoplasia; 2023 Apr; 38():100884. PubMed ID: 36812781
[TBL] [Abstract] [Full Text] [Related]
7. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
[No Abstract] [Full Text] [Related]
8. The prognostic value of a 4-factor neoimmunologic score system in non-small cell lung cancer.
Yang F; Zeng Z; Li Y; Zhang D; Wei F; Zhao H; Zhang P; Ren X
J Leukoc Biol; 2022 Dec; 112(6):1605-1619. PubMed ID: 36073781
[TBL] [Abstract] [Full Text] [Related]
9. Toxicity profile of treatment with pd-1 inhibitors for lung cancer, melanoma and renal cell carcinoma: A real-world Brazilian study.
Duarte HS; Veiga CRP; Veiga CP; Wainstein AJA; Drummond-Lage AP
Int Immunopharmacol; 2022 Jul; 108():108727. PubMed ID: 35397393
[TBL] [Abstract] [Full Text] [Related]
10. Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review.
Satturwar S; Girolami I; Munari E; Ciompi F; Eccher A; Pantanowitz L
Diagn Cytopathol; 2022 Jun; 50(6):313-323. PubMed ID: 35293692
[TBL] [Abstract] [Full Text] [Related]
11. Mediastinal lymph node removal ameliorates cytotoxic T-lymphocyte functions in patients with non-small cell lung cancer.
Engin A; Turna A; Esen F; Agkoc M; Cikman DI; Saglam OF; Deniz G; Aktas EC
Tumori; 2023 Feb; 109(1):97-104. PubMed ID: 34918599
[TBL] [Abstract] [Full Text] [Related]
12. Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell lung cancer.
Deng H; Liu J; Cai X; Chen J; Rocco G; Petersen RH; Brunelli A; Ng CSH; D'Amico TA; Liang W; He J
Ann Surg; 2022 Mar; 275(3):e600-e602. PubMed ID: 34596079
[TBL] [Abstract] [Full Text] [Related]
13. [Correlation Study on Expression of pd-1 and PD-L1 in Non-small Cell lung cancer and Epidermal Growth Factor Receptor Mutations].
Jiang L; Lin Z; Li N; Jiang J; Lu C; Du S; Zhang J; Wang Y; Chen J; Gong P
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):623-631. PubMed ID: 34455737
[TBL] [Abstract] [Full Text] [Related]
14. Usefulness of
Li Y; Li Y; Huang Y; Wu X; Yang Z; Wu C; Jiang L
Ann Nucl Med; 2021 Sep; 35(9):1048-1057. PubMed ID: 34101153
[TBL] [Abstract] [Full Text] [Related]
15. Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study.
Kauffmann-Guerrero D; Kahnert K; Kiefl R; Sellmer L; Walter J; Behr J; Tufman A
Sci Rep; 2021 May; 11(1):10919. PubMed ID: 34035415
[TBL] [Abstract] [Full Text] [Related]
16. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.
Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632
[TBL] [Abstract] [Full Text] [Related]
17. Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.
Gauvin C; Krishnan V; Kaci I; Tran-Thanh D; Bédard K; Albadine R; Leduc C; Gaboury L; Blais N; Tehfe M; Routy B; Florescu M
Curr Oncol; 2021 Jan; 28(1):593-605. PubMed ID: 33498159
[TBL] [Abstract] [Full Text] [Related]
18. Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell lung cancer: Safety and Immunologic Activity.
Predina JD; Haas AR; Martinez M; O'Brien S; Moon EK; Woodruff P; Stadanlick J; Corbett C; Frenzel-Sulyok L; Bryski MG; Eruslanov E; Deshpande C; Langer C; Aguilar LK; Guzik BW; Manzanera AG; Aguilar-Cordova E; Singhal S; Albelda SM
Mol Ther; 2021 Feb; 29(2):658-670. PubMed ID: 33160076
[TBL] [Abstract] [Full Text] [Related]
19. [Operability and Pathological Response of Non-Small Cell lung cancer (NSCLC) after Neoadjuvant Therapy with Immune Checkpoint Inhibition].
Lücke E; Ganzert C; Föllner S; Wäsche A; Jechorek D; Schoeder V; Walles T; Genseke P; Schreiber J
Pneumologie; 2020 Nov; 74(11):766-772. PubMed ID: 32820489
[TBL] [Abstract] [Full Text] [Related]
20. Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC.
Mazzaschi G; Milanese G; Pagano P; Madeddu D; Gnetti L; Trentini F; Falco A; Frati C; Lorusso B; Lagrasta C; Minari R; Ampollini L; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Lung Cancer; 2020 Jun; 144():30-39. PubMed ID: 32361033
[TBL] [Abstract] [Full Text] [Related]
[Next]
